Literature DB >> 22198568

Copper is toxic to PrP-ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease.

Tamar Canello1, Yael Friedman-Levi, Michal Mizrahi, Orli Binyamin, Eran Cohen, Kati Frid, Ruth Gabizon.   

Abstract

The pathogenesis of the diverse forms of prion disease was attributed solely to the accumulation of the misfolded PrP forms, and not to the potential loss of normal PrP(C) function during disease propagation. In this respect, it was also not established whether mutant PrPs linked to genetic prion diseases, as is the case for E200K PrP, preserve the function of PrP(C). We now show that fibroblasts generated from both PrP-ablated mice and TgMHu2ME199K, a transgenic mouse line mimicking E200KCJD, were significantly more sensitive to copper toxicity than wt fibroblasts. Long-term administration of copper significantly accelerated the onset and progression of spontaneous prion disease in TgMHu2ME199K mice and caused marked irritability and cerebellar associated tip-toe walking in PrP(0/0) mice, while wt mice were not affected. Our results are consistent with the hypothesis that a functional PrP(C) is required to protect cells from high levels of copper, and that its substitution for a nonfunctional mutant PrP may accelerate the onset of genetic prion disease during oxidative insults.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198568     DOI: 10.1016/j.nbd.2011.12.020

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  12 in total

1.  The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

Authors:  Feimeng Zhou; Glenn L Millhauser
Journal:  Coord Chem Rev       Date:  2012-05-04       Impact factor: 22.315

2.  Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface.

Authors:  Ann R Spevacek; Eric G B Evans; Jillian L Miller; Heidi C Meyer; Jeffrey G Pelton; Glenn L Millhauser
Journal:  Structure       Date:  2013-01-03       Impact factor: 5.006

3.  Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Authors:  Yael Friedman-Levi; Romana Hoftberger; Herbert Budka; Tehila Mayer-Sonnenfeld; Oded Abramsky; Haim Ovadia; Ruth Gabizon
Journal:  J Neuroinflammation       Date:  2012-03-21       Impact factor: 8.322

Review 4.  Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein.

Authors:  Walker S Jackson
Journal:  Dis Model Mech       Date:  2014-01       Impact factor: 5.758

5.  Bivalent Copper Ions Promote Fibrillar Aggregation of KCTD1 and Induce Cytotoxicity.

Authors:  Zhepeng Liu; Feifei Song; Zhi-Li Ma; Qiushuang Xiong; Jingwen Wang; Deyin Guo; Guihong Sun
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

Review 6.  Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.

Authors:  Mattia Toni; Maria L Massimino; Agnese De Mario; Elisa Angiulli; Enzo Spisni
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

7.  Snord 3A: a molecular marker and modulator of prion disease progression.

Authors:  Eran Cohen; Dana Avrahami; Kati Frid; Tamar Canello; Ephrat Levy Lahad; Sharon Zeligson; Shira Perlberg; Joab Chapman; Oren S Cohen; Esther Kahana; Iris Lavon; Ruth Gabizon
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

8.  Age at Death of Creutzfeldt-Jakob disease in subsequent family generation carrying the E200K mutation of the prion protein gene.

Authors:  Maurizio Pocchiari; Anna Poleggi; Maria Puopolo; Marco D'Alessandro; Dorina Tiple; Anna Ladogana
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

9.  PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease.

Authors:  Yael Friedman-Levi; Michal Mizrahi; Kati Frid; Orli Binyamin; Ruth Gabizon
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Effects of a naturally occurring amino acid substitution in bovine PrP: a model for inherited prion disease in a natural host species.

Authors:  Catherine E Vrentas; Justin J Greenlee; Gregory H Foster; James West; Marianna M Jahnke; Mark T Schmidt; Eric M Nicholson
Journal:  BMC Res Notes       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.